NASDAQ:CHNG - Nasdaq - US15912K1007 - Common Stock - Currency: USD
27.49
+0.07 (+0.26%)
The current stock price of CHNG is 27.49 USD. In the past month the price increased by 11.07%. In the past year, price increased by 30.16%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
Change Healthcare, Inc. engages in the development of a healthcare technology platform that offers data and analytics-driven solutions. The company is headquartered in Nashville, Tennessee and currently employs 14,000 full-time employees. The company went IPO on 2019-06-27. The firm is focused on the transformation of the healthcare system through its Change Healthcare platform. The firm operates through three business segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. Its Software and Analytics segment provide solutions for revenue cycle management, provider network management, payment accuracy, value-based payments, clinical decision support, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. Its Network Solutions segment provide solutions for financial, administrative, and clinical and pharmacy transactions, electronic payments and aggregation and analytics of clinical and financial data. Its Technology-Enabled Services segment provides solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration and healthcare consulting.
CHANGE HEALTHCARE INC
424 Church Street, Suite 1400
Nashville TENNESSEE 37219 US
CEO: Neil E. de Crescenzo
Employees: 14000
Company Website: https://www.changehealthcare.com/
Phone: 16159323000.0
The current stock price of CHNG is 27.49 USD. The price increased by 0.26% in the last trading session.
The exchange symbol of CHANGE HEALTHCARE INC is CHNG and it is listed on the Nasdaq exchange.
CHNG stock is listed on the Nasdaq exchange.
17 analysts have analysed CHNG and the average price target is 27.85 USD. This implies a price increase of 1.32% is expected in the next year compared to the current price of 27.49. Check the CHANGE HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CHANGE HEALTHCARE INC (CHNG) has a market capitalization of 9.03B USD. This makes CHNG a Mid Cap stock.
CHANGE HEALTHCARE INC (CHNG) currently has 14000 employees.
CHANGE HEALTHCARE INC (CHNG) has a support level at 25.72 and a resistance level at 27.5. Check the full technical report for a detailed analysis of CHNG support and resistance levels.
The Revenue of CHANGE HEALTHCARE INC (CHNG) is expected to grow by 3.51% in the next year. Check the estimates tab for more information on the CHNG EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CHNG does not pay a dividend.
CHANGE HEALTHCARE INC (CHNG) will report earnings on 2022-11-02, after the market close.
The PE ratio for CHANGE HEALTHCARE INC (CHNG) is 18.57. This is based on the reported non-GAAP earnings per share of 1.48 and the current share price of 27.49 USD. Check the full fundamental report for a full analysis of the valuation metrics for CHNG.
ChartMill assigns a technical rating of 10 / 10 to CHNG. When comparing the yearly performance of all stocks, CHNG is one of the better performing stocks in the market, outperforming 95.77% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CHNG. CHNG has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months CHNG reported a non-GAAP Earnings per Share(EPS) of 1.48. The EPS decreased by -0.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -2.2% | ||
ROA | -0.8% | ||
ROE | N/A | ||
Debt/Equity | 1.36 |
ChartMill assigns a Buy % Consensus number of 72% to CHNG. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of -1.57% and a revenue growth 3.51% for CHNG